Concepedia

Mark Brody

MB

Statistics

Publications

15

Citations

4.2K

H-Index

14

Active since

1994

Affiliations

Brain Matters Research(Current)

Yale University

Bristol-Myers Squibb (United States)

Compass Research

Brown University

Mark Brody is an author at Brain Matters Research specializing in dementia, alzheimer disease, and neurology.

Publications per year

1994–2025

15

Publications

15

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

Vladimir Coric, Christopher H. van Dyck, Stephen Salloway et al. · Archives of Neurology · 2012 · 369 citations

Medicine, Pharmacology, Pharmacotherapy +17

Jeffrey L. Cummings, Sharon Cohen, Christopher H. van Dyck et al. · Neurology · 2018 · 251 citations · Full text

Medicine, Neurology, Pharmacology +13

Targeting Prodromal Alzheimer Disease With Avagacestat

Vladimir Coric, Stephen Salloway, Christopher H. van Dyck et al. · JAMA Neurology · 2015 · 233 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease

Edmond Teng, Paul T. Manser, Karen Pickthorn et al. · JAMA Neurology · 2022 · 191 citations · Full text

Life Sciences, Neurology, Neuroscience +17

1–5 of 15